References
- El-SeragHBHepatocellular carcinomaN Engl J Med2011365121118112721992124
- HanZGFunctional genomic studies: insights into the pathogenesis of liver cancerAnnu Rev Genomics Hum Genet20121317120522703171
- VillanuevaAHernandez-GeaVLlovetJMMedical therapies for hepatocellular carcinoma: a critical view of the evidenceNat Rev Gastroenterol Hepatol2013101344223147664
- FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
- VisvaderJECells of origin in cancerNature2011469733031432221248838
- WeiKRYuXZhengRSIncidence and mortality of liver cancer in China, 2010Chin J Cancer201433838839425104174
- LudwigJAWeinsteinJNBiomarkers in cancer staging, prognosis and treatment selectionNat Rev Cancer200551184585616239904
- XieBLinWYeJDDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1J Exp Clin Cancer Res20153410126362312
- LiuHLiuYLiuWZhangWXuJEZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinomaNat Commun20156849426404566
- FoCSColemanCSWallickCJVineALBachmannASGenomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2)Gene2006371115416516481131
- DolySMarulloSPRAF2, an endoplasmic reticulum gatekeeper, controls the cell-surface export of the GABA(B) receptor in neuronsMed Sci20153110834836
- Cifuentes-DiazCMarulloSDolySAnatomical and ultrastructural study of PRAF2 expression in the mouse central nervous systemBrain Struct Funct201622184169418526645984
- DolySMarulloSGatekeepers controlling GPCR export and functionTrends Pharmacol Sci2015361063664426435209
- SchwenekerMBachmannASMoellingKJM4 is a four-transmembrane protein binding to the CCR5 receptorFEBS Lett200557971751175815757671
- RuggieroAMLiuYVidenskySThe endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 proteinJ Biol Chem2008283106175618318167356
- ChenHBaiJYeJJWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeletonCell Signal20071961315132717336041
- WangGLShiXSalisburyETimchenkoNARegulation of apoptotic and growth inhibitory activities of C/EBP alpha in different cell linesExp Cell Res200831471626163918313667
- BorsicsTLundbergEGeertsDSubcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migrationCancer Sci201010171624163120412121
- KoomoaDLGoRCWesterKBachmannASExpression profile of PRAF2 in the human brain and enrichment in synaptic vesiclesNeurosci Lett2008436217117618395978
- KimJTChoMYChoiSCPrenylated Rab acceptor 1 (PRA1) inhibits TCF/beta-catenin signaling by binding to beta-cateninBiochem Biophys Res Commun2006349120020816930546
- GeertsDWallickCJKoomoaDLExpression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulationClin Cancer Res200713216312631917975142
- YcoLPGeertsDKosterJBachmannASPRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastomaInt J Oncol20134241408141623440329
- VentoMTZazzuVLoffredaAPraf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cellsPLoS One2010512e1563621203533
- HendrixAWestbroekWBrackeMde WeverOAn ex(o)citing machinery for invasive tumor growthCancer Res201070239533953721098711
- PeinadoFLavotshkinSLydenDThe secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughtsSemin Cancer Biol201121213914621251983